Evaluation of a Single Vaccination With a 4-Antigen Staphylococcus Aureus Vaccine (SA4Ag) in Healthy Adults Aged 18 to <65 Years

PHASE1CompletedINTERVENTIONAL

Enrollment

100

Participants

Timeline

Start Date

January 31, 2015

Primary Completion Date

February 28, 2015

Study Completion Date

February 28, 2015

Conditions

Staphylococcal Infections

Interventions

BIOLOGICAL

SA4Ag vaccine

Subjects receive 1 intramuscular injection (0.5 mL) of the SA4Ag vaccine.

PROCEDURE

Blood sample

Blood for immunogenicity will be collected from all subjects at various timepoints.

Trial Locations (2)

Broward Research Group, Hollywood

Miami Research Associates, South Miami